{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:11:02Z","timestamp":1791893462446,"version":"4.3.4"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,11,23]],"date-time":"2007-11-23T00:00:00Z","timestamp":1195776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s00405-007-0534-3","type":"journal-article","created":{"date-parts":[[2007,11,22]],"date-time":"2007-11-22T08:05:53Z","timestamp":1195718753000},"page":"139-145","source":"Crossref","is-referenced-by-count":29,"title":["Treating common ear problems in pregnancy: what is safe?"],"prefix":"10.1007","volume":"265","author":[{"given":"Petros V.","family":"Vlastarakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P.","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonidas","family":"Manolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Ferekidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kreatsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,23]]},"reference":[{"key":"534_CR1","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/019459988309100330","volume":"91","author":"GR Holt","year":"1983","unstructured":"Holt GR, Mabry RL (1983) ENT medications in pregnancy. Otolaryngol Head Neck Surg 91:338\u201341","journal-title":"Otolaryngol Head Neck Surg"},{"key":"534_CR2","first-page":"1","volume-title":"Will it hurt the baby? The safe use of medications during pregnancy and breastfeeding","author":"RS Abrams","year":"1990","unstructured":"Abrams RS (1990) Will it hurt the baby? The safe use of medications during pregnancy and breastfeeding. Addison-Wesley, Reading, pp 1\u20135"},{"key":"534_CR3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/bmj.293.6559.1415","volume":"293","author":"PC Rubin","year":"1986","unstructured":"Rubin PC (1986) Prescribing in pregnancy. General principles. BMJ 293:1415\u20131417","journal-title":"BMJ"},{"key":"534_CR4","first-page":"131","volume-title":"The developing human: clinically oriented embryology","author":"KL Moore","year":"1988","unstructured":"Moore KL (1988) The developing human: clinically oriented embryology, 4th edn. W.B. Saunders, Philadelphia, p 131","edition":"4th"},{"issue":"5","key":"534_CR5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2165\/00002018-199716050-00005","volume":"16","author":"M Schatz","year":"1997","unstructured":"Schatz M (1997) Asthma treatment during pregnancy. What can be safely taken? Drug Saf 16(5):342\u2013350","journal-title":"Drug Saf"},{"key":"534_CR6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1651-2227.1970.tb09007.x","volume":"59","author":"H Ekelund","year":"1970","unstructured":"Ekelund H, Kullander S, Kallen B (1970) Major and minor malformations in newborns and infants up to one year of age. Acta Paediatr Scand 59:297\u2013302","journal-title":"Acta Paediatr Scand"},{"key":"534_CR7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1136\/jmg.14.5.305","volume":"14","author":"P Ash","year":"1977","unstructured":"Ash P, Vennart J, Carter CO (1977) The incidence of hereditary disease in man. J Med Genet 14:305","journal-title":"J Med Genet"},{"issue":"7","key":"534_CR8","first-page":"483","volume":"60","author":"F Sa Fiol del","year":"2005","unstructured":"Sa del Fiol F, Gerenutti M, Groppo FC (2005) Antibiotics and pregnancy. Pharmazie 60(7):483\u2013493","journal-title":"Pharmazie"},{"issue":"10 Suppl","key":"534_CR9","doi-asserted-by":"crossref","first-page":"S390","DOI":"10.1097\/01.CCM.0000182483.24836.66","volume":"33","author":"WH Goodnight","year":"2005","unstructured":"Goodnight WH, Soper DE (2005) Pneumonia in pregnancy. Crit Care Med 33(10 Suppl):S390\u2013S397","journal-title":"Crit Care Med"},{"issue":"3","key":"534_CR10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF03256651","volume":"2","author":"WS Lim","year":"2003","unstructured":"Lim WS, Macfarlane JT, Colthorpe CL (2003) Treatment of community-acquired lower respiratory tract infections during pregnancy. Am J Respir Med 2(3):221\u2013233","journal-title":"Am J Respir Med"},{"issue":"6","key":"534_CR11","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1526-9523(02)00330-6","volume":"47","author":"EL Miller","year":"2002","unstructured":"Miller EL (2002) The penicillins: a review and update. J Midwifery Womens Health 47(6):426\u2013434","journal-title":"J Midwifery Womens Health"},{"issue":"Suppl 1","key":"534_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jac\/46.suppl_1.29","volume":"46","author":"B Christensen","year":"2000","unstructured":"Christensen B (2000) Which antibiotics are appropriate for treating bacteriuria in pregnancy? J Antimicrob Chemother 46(Suppl 1):29\u201334 discussion 63\u201365","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"534_CR13","first-page":"338","volume":"55","author":"B Rouveix","year":"1999","unstructured":"Rouveix B, Levacher M, Giroud JP (1999) Drugs for respiratory tropism and pregnancy (article in French). Rev Pneumol Clin 55(5):338\u2013343","journal-title":"Rev Pneumol Clin"},{"issue":"3","key":"534_CR14","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2165\/00002018-199513030-00004","volume":"13","author":"SM Garland","year":"1995","unstructured":"Garland SM, O\u2019Reilly MA (1995) The risks and benefits of antimicrobial therapy in pregnancy Drug Saf 13(3):188\u2013205","journal-title":"Drug Saf"},{"issue":"4","key":"534_CR15","first-page":"111","volume":"21","author":"K Friese","year":"1993","unstructured":"Friese K (1993) Antibiotic therapy in pregnancy (article in German). Immun Infekt 21(4):111\u2013114","journal-title":"Immun Infekt"},{"issue":"3","key":"534_CR16","first-page":"293","volume":"5","author":"P Leophonte","year":"1988","unstructured":"Leophonte P (1988) Antibiotics during pregnancy and breast feeding: consequences for the treatment of respiratory infections. Rev Mal Respir 5(3):293\u2013298","journal-title":"Rev Mal Respir"},{"issue":"3","key":"534_CR17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1385\/CRIAI:26:3:149","volume":"26","author":"EK Ellegard","year":"2004","unstructured":"Ellegard EK (2004) Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol 26(3):149\u2013159","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"534_CR18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/00003088-199427010-00005","volume":"27","author":"A Heikkila","year":"1994","unstructured":"Heikkila A, Erkkola R (1994) Review of beta-lactam antibiotics in pregnancy. The need for adjustment of dosage schedules. Clin Pharmacokinet 27(1):49\u201362","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"534_CR19","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0306-3356(21)00005-4","volume":"13","author":"JC Mucklow","year":"1986","unstructured":"Mucklow JC (1986) The fate of drugs in pregnancy. Clin Obstet Gynaecol 13(2):161\u2013175","journal-title":"Clin Obstet Gynaecol"},{"key":"534_CR20","doi-asserted-by":"crossref","unstructured":"Brocklehurst P (2002) Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev (2):CD000098","DOI":"10.1002\/14651858.CD000098"},{"issue":"9","key":"534_CR21","first-page":"223","volume":"145","author":"G Di Lorenzo","year":"1994","unstructured":"Di Lorenzo G, Mansueto P, Melluso M, Purello D\u2019Ambrosio F, Putignano E, Barbagallo Sangiorgi G (1994) Allergy in pregnancy (article in Italian). Clin Ter 145(9):223\u2013229","journal-title":"Clin Ter"},{"issue":"5","key":"534_CR22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2393-6-18","volume":"6","author":"M Sarkar","year":"2006","unstructured":"Sarkar M, Woodland C, Koren G, Einarson AR (2006) Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth 6(5):18","journal-title":"BMC Pregnancy Childbirth"},{"issue":"2","key":"534_CR23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.reprotox.2005.01.010","volume":"20","author":"BA K\u00e4ll\u00e9n","year":"2005","unstructured":"K\u00e4ll\u00e9n BA, Otterblad Olausson P, Danielsson BR (2005) Is erythromycin therapy teratogenic in humans? Reprod Toxicol 20(2):209\u2013214","journal-title":"Reprod Toxicol"},{"issue":"3","key":"534_CR24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","volume":"17","author":"BA K\u00e4ll\u00e9n","year":"2003","unstructured":"K\u00e4ll\u00e9n BA, Otterblad Olausson P (2003) Maternal drug use in early pregnancy and infant cardiovascular defect. Reprod Toxicol 17(3):255\u2013261","journal-title":"Reprod Toxicol"},{"issue":"6","key":"534_CR25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0890-6238(99)00046-5","volume":"13","author":"A Czeizel","year":"1999","unstructured":"Czeizel A, Rockenbauer M, S\u00f8rensen HT, Olsen J (1999) A population-based case-control teratologic study of oral erythromycin treatment during pregnancy. Reprod Toxicol 13(6):531\u2013536","journal-title":"Reprod Toxicol"},{"issue":"2","key":"534_CR26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1067\/mob.2002.119718","volume":"186","author":"C Louik","year":"2002","unstructured":"Louik C, Werler MM, Mitchell AA (2002) Erythromycin use during pregnancy in relation to pyloric stenosis. Am J Obstet Gynecol 186(2):288\u2013290","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"534_CR27","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0149-2918(96)80179-2","volume":"18","author":"GW Amsden","year":"1996","unstructured":"Amsden GW (1996) Erythromycin, clarithromycin, and azithromycin: are the differences real? Clin Ther 18(1):56\u201372 discussion 55","journal-title":"Clin Ther"},{"issue":"3","key":"534_CR28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14767050500439657","volume":"19","author":"JY Chun","year":"2006","unstructured":"Chun JY, Han JY, Ahn HK, Choi JS, Koong MK, Nava-Ocampo AA, Koren G (2006) Fetal outcome following roxithromycin exposure in early pregnancy. J Matern Fetal Neonatal Med 19(3):189\u201392","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"534_CR29","first-page":"347","volume":"53","author":"E Bogacka","year":"1999","unstructured":"Bogacka E (1999) Decongestants in treatment of nasal obstruction (article in Polish\/abstract). Otolaryngol Pol 53(3):347\u2013352","journal-title":"Otolaryngol Pol"},{"issue":"4","key":"534_CR30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00002018-199920040-00005","volume":"20","author":"P Mazzotta","year":"1999","unstructured":"Mazzotta P, Loebstein R, Koren G (1999) Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf 20(4):361\u2013375","journal-title":"Drug Saf"},{"issue":"Suppl 6","key":"534_CR31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1365-2222.1998.0280s6054.x","volume":"28","author":"RM Naclerio","year":"1998","unstructured":"Naclerio RM (1998) Optimizing treatment options. Clin Exp Allergy 28(Suppl 6):54\u201359","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"534_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00002018-200528080-00005","volume":"28","author":"C Gilbert","year":"2005","unstructured":"Gilbert C, Mazzotta P, Loebstein R, Koren G (2005) Fetal safety of drugs used in the treatment of allergic rhinitis: a critical review. Drug Saf 28(8):707\u2013719","journal-title":"Drug Saf"},{"issue":"1","key":"534_CR33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/194589240401800106","volume":"18","author":"N Keles","year":"2004","unstructured":"Keles N (2004) Treatment of allergic rhinitis during pregnancy. Am J Rhinol 18(1):23\u201328","journal-title":"Am J Rhinol"},{"issue":"3","key":"534_CR34","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0091-6749(97)70241-0","volume":"100","author":"M Schatz","year":"1997","unstructured":"Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar L, Petitti D (1997) The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol 100(3):301\u2013306","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"534_CR35","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2165\/00003495-200363170-00004","volume":"63","author":"P Demoly","year":"2003","unstructured":"Demoly P, Piette V, Daures JP (2003) Treatment of allergic rhinitis during pregnancy (article in French). Drugs 63(17):1813\u20131820","journal-title":"Drugs"},{"issue":"3","key":"534_CR36","first-page":"168","volume":"42","author":"E Gilbert-Barness","year":"2000","unstructured":"Gilbert-Barness E, Drut RM (2000) Association of sympathomimetic drugs with malformations. Vet Hum Toxicol 42(3):168\u2013171","journal-title":"Vet Hum Toxicol"},{"issue":"1","key":"534_CR37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/tera.1420360117","volume":"36","author":"KE Ugen","year":"1987","unstructured":"Ugen KE, Scott WJ Jr (1987) Reduction of uterine blood flow by phenylephrine, an alpha-adrenergic agonist, in the day 11 pregnant rat: relationship to potentiation of acetazolamide teratogenesis. Teratology 36(1):133\u2013141","journal-title":"Teratology"},{"key":"534_CR38","unstructured":"No authors listed (2000) The use of newer asthma and allergy medications during pregnancy. The American College of Obstetricians and Gynecologists (ACOG) and The American College of Allergy, Asthma and Immunology (ACAAI). Ann Allergy Asthma Immunol 84(5):475\u2013480"},{"key":"534_CR39","unstructured":"No authors listed (2004) Gastroschisis and pseudoephedrine during pregnancy. Prescrire Int 13(72):141\u2013143"},{"issue":"6","key":"534_CR40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/bdra.20255","volume":"76","author":"MM Werler","year":"2006","unstructured":"Werler MM (2006) Teratogen update: pseudoephedrine. Birth Defects Res A Clin Mol Teratol 76(6):445\u2013452","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"534_CR41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1096-9926(199606)54:2<84::AID-TERA4>3.0.CO;2-4","volume":"54","author":"CP Torfs","year":"1996","unstructured":"Torfs CP, Katz EA, Bateson TF, Lam PK, Curry CJ (1996) Maternal medications and environmental exposures as risk factors for gastroschisis. Teratology 54(2):84\u201392","journal-title":"Teratology"},{"issue":"4","key":"534_CR42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/tera.1420450407","volume":"45","author":"MM Werler","year":"1992","unstructured":"Werler MM, Mitchell AA, Shapiro S (1992) First trimester maternal medication use in relation to gastroschisis. Teratology 45(4):361\u2013367","journal-title":"Teratology"},{"issue":"6 Suppl 3","key":"534_CR43","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S1081-1206(10)61655-9","volume":"90","author":"MS Blaiss","year":"2003","unstructured":"Blaiss MS (2003) Food, drug administration (US); ACAAI\u2013ACOG (American College of Allergy, Asthma, and Immunology and American College of Obstetricians and Gynecologists). Management of rhinitis and asthma in pregnancy. Ann Allergy Asthma Immunol 90(6 Suppl 3):16\u201322","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"7","key":"534_CR44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1185\/030079905X50570","volume":"21","author":"PA Gluck","year":"2005","unstructured":"Gluck PA, Gluck JC (2005) A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide. Curr Med Res Opin 21(7):1075\u20131084","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"534_CR45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/jwh.2005.14.263","volume":"14","author":"SL Osur","year":"2005","unstructured":"Osur SL (2005) The management of asthma and rhinitis during pregnancy. J Womens Health (Larchmt) 14(3):263\u2013276","journal-title":"J Womens Health (Larchmt)"},{"issue":"8","key":"534_CR46","first-page":"306","volume":"35","author":"F Gani","year":"2003","unstructured":"Gani F, Braida A, Lombardi C, Del Giudice A, Senna GE, Passalacqua G (2003) Rhinitis in pregnancy. Allerg Immunol (Paris) 35(8):306\u2013313","journal-title":"Allerg Immunol (Paris)"},{"issue":"10","key":"534_CR47","first-page":"399","volume":"33","author":"A Paris-Kohler","year":"2001","unstructured":"Paris-Kohler A, Megret-Gabeaud ML, Fabre C, Mares P, Vincent D (2001) The allergic pregnant woman (article in French). Allerg Immunol (Paris) 33(10):399\u2013403","journal-title":"Allerg Immunol (Paris)"},{"issue":"7","key":"534_CR48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00002018-200124070-00006","volume":"24","author":"G Bothamley","year":"2001","unstructured":"Bothamley G (2001) Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf 24(7):553\u2013565","journal-title":"Drug Saf"},{"issue":"6","key":"534_CR49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/beog.2001.0241","volume":"15","author":"H Shehata","year":"2001","unstructured":"Shehata H, Nelson-Piercy C (2001) Drugs to avoid. Best Pract Res Clin Obstet Gynaecol 15(6):971\u2013986","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"3","key":"534_CR50","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1517\/14656566.5.3.571","volume":"5","author":"ME Ostensen","year":"2004","unstructured":"Ostensen ME, Skomsvoll JF (2004) Anti-inflammatory pharmacotherapy during pregnancy. Expert Opin Pharmacother 5(3):571\u201380","journal-title":"Expert Opin Pharmacother"},{"issue":"31","key":"534_CR51","first-page":"1462","volume":"31","author":"L Fardet","year":"2002","unstructured":"Fardet L, Nizard J, Genereau T (2002) Non-selective and selective non-steroidal anti-inflammatory drugs, administration in pregnancy and breast feeding (article in French). Presse Med 31(31):1462\u20131468","journal-title":"Presse Med"},{"issue":"63","key":"534_CR52","first-page":"266","volume":"11","author":"F Burdan","year":"2001","unstructured":"Burdan F, Belzek A (2001) Current opinions on embryotoxic and teratogenic effects of ibuprofen (article in Polish\/abstract). Pol Merkuriusz Lek 11(63):266\u2013270","journal-title":"Pol Merkuriusz Lek"},{"key":"534_CR53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/03009742.1998.11720787","volume":"107","author":"M Ostensen","year":"1998","unstructured":"Ostensen M (1998) Nonsteroidal anti-inflammatory drugs during pregnancy. Scand J Rheumatol Suppl 107:128\u2013132","journal-title":"Scand J Rheumatol Suppl"},{"issue":"5","key":"534_CR54","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00002018-199819050-00006","volume":"19","author":"M Ostensen","year":"1998","unstructured":"Ostensen M, Ramsey-Goldman R (1998) Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options? Drug Saf 19(5):389\u2013410","journal-title":"Drug Saf"},{"issue":"6","key":"534_CR55","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2165\/00003088-199427060-00006","volume":"27","author":"M Ostensen","year":"1994","unstructured":"Ostensen M (1994) Optimisation of antirheumatic drug treatment in pregnancy. Clin Pharmacokinet 27(6):486\u2013503","journal-title":"Clin Pharmacokinet"},{"issue":"3\u20134","key":"534_CR56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1600-0897.1992.tb00777.x","volume":"28","author":"A Schoenfeld","year":"1992","unstructured":"Schoenfeld A, Bar Y, Merlob P, Ovadia Y (1992) NSAIDs: maternal and fetal considerations. Am J Reprod Immunol 28(3\u20134):141\u2013147","journal-title":"Am J Reprod Immunol"},{"issue":"62","key":"534_CR57","first-page":"182","volume":"11","author":"F Burdan","year":"2001","unstructured":"Burdan F (2001) Prenatal effects of acetylsalicylic acid (article in Polish\/abstract). Pol Merkuriusz Lek 11(62):182\u2013186","journal-title":"Pol Merkuriusz Lek"},{"issue":"12","key":"534_CR58","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2165\/00002018-200124120-00003","volume":"24","author":"M Santis De","year":"2001","unstructured":"De Santis M, Carducci B, Cavaliere AF, De Santis L, Straface G, Caruso A (2001) Drug-induced congenital defects: strategies to reduce the incidence. Drug Saf 24(12):889\u2013901","journal-title":"Drug Saf"},{"issue":"5","key":"534_CR59","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1001\/archinte.160.5.610","volume":"160","author":"NM Janssen","year":"2000","unstructured":"Janssen NM, Genta MS (2000) The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 160(5):610\u2013619","journal-title":"Arch Intern Med"},{"issue":"4","key":"534_CR60","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0950-3579(98)80045-9","volume":"12","author":"JT Gran","year":"1998","unstructured":"Gran JT, Ostensen M (1998) Spondyloarthritides in females. Baillieres Clin Rheumatol 12(4):695\u2013715","journal-title":"Baillieres Clin Rheumatol"},{"issue":"5","key":"534_CR61","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00002018-199819050-00005","volume":"19","author":"V Pfaffenrath","year":"1998","unstructured":"Pfaffenrath V, Rehm M (1998) Migraine in pregnancy: what are the safest treatment options? Drug Saf 19(5):383\u2013388","journal-title":"Drug Saf"},{"issue":"1","key":"534_CR62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/aje\/155.1.26","volume":"155","author":"MM Werler","year":"2002","unstructured":"Werler MM, Sheehan JE, Mitchell AA (2002) Maternal medication use and risks of gastroschisis and small intestinal atresia. Am J Epidemiol 155(1):26\u201331","journal-title":"Am J Epidemiol"},{"issue":"4","key":"534_CR63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0890-6238(01)00137-X","volume":"15","author":"A Ericson","year":"2001","unstructured":"Ericson A, K\u00e4ll\u00e9n BA (2001) Nonsteroidal anti-inflammatory drugs in early pregnancy. Reprod Toxicol 15(4):371\u2013375","journal-title":"Reprod Toxicol"},{"issue":"11","key":"534_CR64","first-page":"820","volume":"143","author":"Y Yodfat","year":"2004","unstructured":"Yodfat Y (2004) Is there a future for COX-2 inhibitors? (article in Hebrew\/abstract) Harefuah 143(11):820\u2013824 837","journal-title":"Harefuah"},{"issue":"7","key":"534_CR65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2165\/00002018-200427070-00001","volume":"27","author":"VS Chan","year":"2004","unstructured":"Chan VS (2004) A mechanistic perspective on the specificity and extent of COX-2 inhibition in pregnancy. Drug Saf 27(7):421\u2013426","journal-title":"Drug Saf"},{"issue":"2","key":"534_CR66","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00003495-200363992-00003","volume":"63","author":"B Bannwarth","year":"2003","unstructured":"Bannwarth B, Pehourcq F (2003) Pharmacologic basis for using paracetamol: pharmacokinetic and pharmacodynamic issues. Drugs 63(2):5\u201313","journal-title":"Drugs"},{"issue":"3","key":"534_CR67","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2125.2004.02138.x","volume":"58","author":"M Berkovitch","year":"2004","unstructured":"Berkovitch M, Diav-Citrin O, Greenberg R, Cohen M, Bulkowstein M, Shechtman S, Bortnik O, Arnon J, Ornoy A (2004) First-trimester exposure to amoxycillin\/clavulanic acid: a prospective, controlled study. Br J Clin Pharmacol 58(3):298\u2013302","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"534_CR68","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0301-2115(00)00545-5","volume":"97","author":"AE Czeizel","year":"2001","unstructured":"Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J (2001) Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study. Eur J Obstet Gynecol Reprod Biol 97(2):188\u2013192","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"534_CR69","unstructured":"Fairbanks DNF (2003) Pocket guide to antimicrobial therapy in otolaryngology-head and neck surgery, 11th edn. American Academy of Otolaryngology-Head and Neck Surgery Foundation"},{"issue":"3","key":"534_CR70","first-page":"394","volume":"60","author":"KY Loh","year":"2005","unstructured":"Loh KY, Sivalingam N (2005) Understanding hyperemesis gravidarum. Med J Malaysia 60(3):394\u2013399. Quiz 400","journal-title":"Med J Malaysia"},{"issue":"2","key":"534_CR71","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00002018-199819020-00006","volume":"19","author":"C Nelson-Piercy","year":"1998","unstructured":"Nelson-Piercy C (1998) Treatment of nausea and vomiting in pregnancy. When should it be treated and what can be safely taken? Drug Saf 19(2):155\u2013164","journal-title":"Drug Saf"},{"issue":"5 Suppl Underst","key":"534_CR72","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1067\/mob.2002.122596","volume":"186","author":"LA Magee","year":"2002","unstructured":"Magee LA, Mazzotta P, Koren G (2002) Evidence-based view of safety and effectiveness of pharmacologic therapy for nausea and vomiting of pregnancy (NVP). Am J Obstet Gynecol 186(5 Suppl Understanding):S256\u2013S261","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"534_CR73","first-page":"1169","volume":"69","author":"ZA Flake","year":"2004","unstructured":"Flake ZA, Scalley RD, Bailey AG (2004) Practical selection of antiemetics. Am Fam Physician 69(5):1169\u20131174","journal-title":"Am Fam Physician"},{"issue":"8","key":"534_CR74","first-page":"660","volume":"5","author":"AM Leathem","year":"1986","unstructured":"Leathem AM (1986) Safety and efficacy of antiemetics used to treat nausea and vomiting in pregnancy. Clin Pharm 5(8):660\u2013668","journal-title":"Clin Pharm"},{"issue":"50","key":"534_CR75","first-page":"32","volume":"144","author":"O Schroder","year":"2002","unstructured":"Schroder O, Stein J (2002) Vomiting in pregnancy. When is it more than only a bothersome nuisance? (article in German). MMW Fortschr Med 144(50):32\u201334","journal-title":"MMW Fortschr Med"},{"key":"534_CR76","doi-asserted-by":"crossref","unstructured":"Jewell D, Young G (2003) Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev (4):CD000145","DOI":"10.1002\/14651858.CD000145"},{"issue":"1","key":"534_CR77","first-page":"25","volume":"15","author":"E Langner","year":"1998","unstructured":"Langner E, Greifenberg S, Gruenwald J (1998) Ginger: history and use. Adv Ther 15(1):25\u201344","journal-title":"Adv Ther"},{"issue":"4","key":"534_CR78","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.AOG.0000154890.47642.23","volume":"105","author":"F Borrelli","year":"2005","unstructured":"Borrelli F, Capasso R, Aviello G, Pittler MH, Izzo AA (2005) Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol 105(4):849\u2013856","journal-title":"Obstet Gynecol"},{"issue":"1","key":"534_CR79","first-page":"14","volume":"12","author":"O Betz","year":"2005","unstructured":"Betz O, Kranke P, Geldner G, Wulf H, Eberhart LH (2005) Is ginger a clinically relevant antiemetic? A systematic review of randomized controlled trials (article in German). Forsch Komplementarmed Klass Naturheilkd 12(1):14\u201323","journal-title":"Forsch Komplementarmed Klass Naturheilkd"},{"issue":"1","key":"534_CR80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmwh.2004.08.023","volume":"50","author":"E Bryer","year":"2005","unstructured":"Bryer E (2005) A literature review of the effectiveness of ginger in alleviating mild-to-moderate nausea and vomiting of pregnancy. J Midwifery Womens Health 50(1):1\u20133","journal-title":"J Midwifery Womens Health"},{"key":"534_CR81","unstructured":"http:\/\/www.medicinenet.com"},{"issue":"5","key":"534_CR82","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000276956","volume":"59","author":"K Uchide","year":"1997","unstructured":"Uchide K, Suzuki N, Takiguchi T, Terada S, Inoue M (1997) The possible effect of pregnancy on Meniere\u2019s disease. ORL J Otorhinolaryngol Relat Spec 59(5):292\u2013295","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"3","key":"534_CR83","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2165\/00002018-199207030-00007","volume":"7","author":"PM Kyle","year":"1992","unstructured":"Kyle PM, Redman CW (1992) Comparative risk-benefit assessment of drugs used in the management of hypertension in pregnancy. Drug Saf 7(3):223\u2013234","journal-title":"Drug Saf"},{"issue":"2","key":"534_CR84","first-page":"151","volume":"23","author":"L Hansen","year":"1986","unstructured":"Hansen L, Sobol S, Abelson T (1986) Otolalyngologic manifestations of pregnancy. J Fam Pract 23(2):151\u2013155","journal-title":"J Fam Pract"},{"issue":"6","key":"534_CR85","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1024\/0040-5930.57.6.408","volume":"57","author":"U Huynh-Do","year":"2000","unstructured":"Huynh-Do U, Frey FJ (2000) Potential dangers of diuretics (article in German). Ther Umsch 57(6):408\u2013411","journal-title":"Ther Umsch"},{"key":"534_CR86","first-page":"1083","volume":"50","author":"D Oren","year":"2004","unstructured":"Oren D, Nulman I, Makhija M, Ito S, Koren G (2004) Using corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk? Can Fam Physician 50:1083\u20131085","journal-title":"Can Fam Physician"},{"issue":"3","key":"534_CR87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/sper.2001.24569","volume":"25","author":"M Schatz","year":"2001","unstructured":"Schatz M (2001) The efficacy and safety of asthma medications during pregnancy. Semin Perinatol 25(3):145\u2013152","journal-title":"Semin Perinatol"},{"issue":"6","key":"534_CR88","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","volume":"62","author":"L Park-Wyllie","year":"2000","unstructured":"Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D, Diav-Citrin O, Chitayat D, Nulman I, Einarson TR, Koren G (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6):385\u2013392","journal-title":"Teratology"},{"issue":"8","key":"534_CR89","first-page":"565","volume":"82","author":"BT Ambro","year":"2003","unstructured":"Ambro BT, Scheid SC, Pribitkin EA (2003) Prescribing guidelines for ENT medications during pregnancy. ENT J 82(8):565\u2013568","journal-title":"ENT J"},{"key":"534_CR90","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/03009742.1998.11720789","volume":"107","author":"MD Lockshin","year":"1998","unstructured":"Lockshin MD, Sammaritano LR (1998) Corticosteroids during pregnancy. Scand J Rheumatol Suppl 107:136\u2013138","journal-title":"Scand J Rheumatol Suppl"},{"issue":"2","key":"534_CR91","first-page":"160","volume":"25","author":"M Guillonneau","year":"1996","unstructured":"Guillonneau M, Jacqz-Aigrain E (1996) Maternal corticotherapy. Pharmacology and effect on the fetus (article in French). J Gynecol Obstet Biol Reprod (Paris) 25(2):160\u2013167","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"4","key":"534_CR92","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.reprotox.2004.09.002","volume":"19","author":"H Garbis","year":"2005","unstructured":"Garbis H, Elefant E, Diav-Citrin O, Schaefer C, Vial T, Clementi M, Valti E, McElhatton P, Smorlesi C, Rodriguez EP, Robert-Gnansia E, Merlob P, Peiker G, Pexieder T, Schueler L, Ritvanen A, Mathieu-Nolf M (2005) Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services. Reprod Toxicol 19(4):453\u2013458","journal-title":"Reprod Toxicol"},{"issue":"1","key":"534_CR93","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0889-8553(02)00063-8","volume":"32","author":"MS Cappell","year":"2003","unstructured":"Cappell MS (2003) Gastric and duodenal ulcers during pregnancy. Gastroenterol Clin North Am 32(1):263\u2013308","journal-title":"Gastroenterol Clin North Am"},{"issue":"1","key":"534_CR94","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11938-001-0049-8","volume":"4","author":"M Charan","year":"2001","unstructured":"Charan M, Katz PO (2001) Gastroesophageal reflux disease in pregnancy. Curr Treat Options Gastroenterol 4(1):73\u201381","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"4","key":"534_CR95","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0889-8553(21)00603-8","volume":"21","author":"PA Michaletz-Onody","year":"1992","unstructured":"Michaletz-Onody PA (1992) Peptic ulcer disease in pregnancy. Gastroenterol Clin North Am 21(4):817\u2013826","journal-title":"Gastroenterol Clin North Am"},{"issue":"2","key":"534_CR96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.gco.0000192974.61729.4c","volume":"18","author":"PM Kyle","year":"2006","unstructured":"Kyle PM (2006) Drugs and the fetus. Curr Opin Obstet Gynecol 18(2):93\u201399","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"3","key":"534_CR97","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2036.2005.02306.x","volume":"21","author":"O Diav-Citrin","year":"2005","unstructured":"Diav-Citrin O, Arnon J, Shechtman S, Schaefer C, van Tonningen MR, Clementi M, De Santis M, Robert-Gnansia E, Valti E, Malm H, Ornoy A (2005) The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled study. Aliment Pharmacol Ther 21(3):269\u2013275","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"534_CR98","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0889-8553(02)00065-1","volume":"32","author":"JE Richter","year":"2003","unstructured":"Richter JE (2003) Gastroesophageal reflux disease during pregnancy. Gastroenterol Clin North Am 32(1):235\u2013261","journal-title":"Gastroenterol Clin North Am"},{"issue":"7","key":"534_CR99","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1023\/A:1015863018105","volume":"47","author":"S Nikfar","year":"2002","unstructured":"Nikfar S, Abdollahi M, Moretti ME, Magee LA, Koren G (2002) Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis. Dig Dis Sci 47(7):1526\u20131529","journal-title":"Dig Dis Sci"},{"issue":"8","key":"534_CR100","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1046\/j.1365-2036.1999.00578.x","volume":"13","author":"GL Nielsen","year":"1999","unstructured":"Nielsen GL, Sorensen HT, Thulstrup AM, Tage-Jensen U, Olesen C, Ekbom A (1999) The safety of proton pump inhibitors in pregnancy. Aliment Pharmacol Ther 13(8):1085\u20131089","journal-title":"Aliment Pharmacol Ther"},{"key":"534_CR101","first-page":"853","volume":"52","author":"AA Nava-Ocampo","year":"2006","unstructured":"Nava-Ocampo AA, Vel\u00e1zquez-Armenta EY, Han JY, Koren G (2006) Use of proton pump inhibitors during pregnancy and breastfeeding. Can Fam Physician 52:853\u2013854","journal-title":"Can Fam Physician"},{"issue":"1","key":"534_CR102","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-2115(00)00388-2","volume":"96","author":"BA K\u00e4ll\u00e9n","year":"2001","unstructured":"K\u00e4ll\u00e9n BA (2001) Use of omeprazole during pregnancy-no hazard demonstrated in 955 infants exposed during pregnancy. Eur J Obstet Gynecol Reprod Biol 96(1):63\u201368","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"Suppl 1","key":"534_CR103","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1086\/342966","volume":"186","author":"SK Tyring","year":"2002","unstructured":"Tyring SK, Baker D, Snowden W (2002) Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20\u00a0years\u2019 experience with acyclovir. J Infect Dis 186(Suppl 1):S40\u2013S46","journal-title":"J Infect Dis"},{"issue":"5","key":"534_CR104","first-page":"679","volume":"18","author":"J Haddad","year":"1989","unstructured":"Haddad J, Messer J, Willard D, Ritter J (1989) Acyclovir and pregnancy: current aspects (article in French). J Gynecol Obstet Biol Reprod (Paris) 18(5):679\u2013683","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"issue":"1","key":"534_CR105","first-page":"38","volume":"13","author":"M May","year":"1980","unstructured":"May M (1980) Bell\u2019s palsy: diagnosis, prognosis and treatment. Surg Rounds 13(1):38\u201348","journal-title":"Surg Rounds"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-007-0534-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-007-0534-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-007-0534-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T19:05:17Z","timestamp":1630177517000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-007-0534-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,23]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s00405-007-0534-3","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,23]]}}}